Schizophrenia.
Nadeem
Zia
Z
Department of Psychiatry, Edinburgh, UK.
McIntosh
Andrew
A
Lawrie
Stephen
S
D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003024:Clozapine / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D003988:Dibenzothiepins / Q000627:therapeutic use; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D000077152:Olanzapine; D010349:Patient Compliance; D010464:Perazine / Q000627:therapeutic use; D010868:Pimozide / Q000627:therapeutic use; D018967:Risperidone / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy* / Q000628:therapy; D013469:Sulpiride / Q000031:analogs & derivatives* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D003988:Dibenzothiepins; D001569:Benzodiazepines; D010868:Pimozide; D013469:Sulpiride; D000077582:Amisulpride; D010464:Perazine; D003024:Clozapine; D006220:Haloperidol; D018967:Risperidone; D000077152:Olanzapine; C022172:zotepine; D002746:Chlorpromazine